Legal & General Group’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-16,433
| Closed | -$393K | – | 3777 |
|
|
2021
Q1 | $393K | Buy |
16,433
+1,673
| +11% | +$31.1K | ﹤0.01% | 2336 |
|
|
2020
Q4 | $215K | Sell |
14,760
-76
| -0.5% | -$1.01K | ﹤0.01% | 2401 |
|
|
2020
Q3 | $211K | Sell |
14,836
-2,810
| -16% | -$42.9K | ﹤0.01% | 2347 |
|
|
2020
Q2 | $260K | Buy |
17,646
+786
| +5% | +$7.99K | ﹤0.01% | 2306 |
|
|
2020
Q1 | $70K | Sell |
16,860
-3,098
| -16% | -$14.5K | ﹤0.01% | 2506 |
|
|
2019
Q4 | $96K | Buy |
19,958
+2,237
| +13% | +$12.3K | ﹤0.01% | 2602 |
|
|
2019
Q3 | $108K | Buy |
17,721
+4,234
| +31% | +$26.4K | ﹤0.01% | 2498 |
|
|
2019
Q2 | $88K | Buy |
13,487
+1,274
| +10% | +$8.98K | ﹤0.01% | 2575 |
|
|
2019
Q1 | $87K | Buy |
12,213
+905
| +8% | +$5.96K | ﹤0.01% | 2535 |
|
|
2018
Q4 | $55K | Buy |
11,308
+3,700
| +49% | +$19.3K | ﹤0.01% | 2662 |
|
|
2018
Q3 | $56K | Hold |
7,608
| – | – | ﹤0.01% | 2720 |
|
|
2018
Q2 | $49K | Sell |
7,608
-1,892
| -20% | -$12.5K | ﹤0.01% | 2759 |
|
|
2018
Q1 | $51K | Sell |
9,500
-3,452
| -27% | -$17.2K | ﹤0.01% | 2746 |
|
|
2017
Q4 | $55K | Hold |
12,952
| – | – | ﹤0.01% | 2835 |
|
|
2017
Q3 | $124K | Buy |
12,952
+1,431
| +12% | +$14.9K | ﹤0.01% | 2530 |
|
|
2017
Q2 | $137K | Buy |
11,521
+240
| +2% | +$3.07K | ﹤0.01% | 2450 |
|
|
2017
Q1 | $145K | Sell |
11,281
-149
| -1% | -$1.79K | ﹤0.01% | 2382 |
|
|
2016
Q4 | $141K | Buy |
11,430
+4,343
| +61% | +$51.6K | ﹤0.01% | 2368 |
|
|
2016
Q3 | $78K | Sell |
7,087
-1,040
| -13% | -$10K | ﹤0.01% | 2316 |
|
|
2016
Q2 | $69K | Hold |
8,127
| – | – | ﹤0.01% | 2308 |
|
|
2016
Q1 | $42K | Hold |
8,127
| – | – | ﹤0.01% | 2488 |
|
|
2015
Q4 | $62K | Hold |
8,127
| – | – | ﹤0.01% | 2349 |
|
|
2015
Q3 | $62K | Hold |
8,127
| – | – | ﹤0.01% | 2334 |
|
|
2015
Q2 | $75K | Hold |
8,127
| – | – | ﹤0.01% | 2331 |
|
|
2015
Q1 | $108K | Hold |
8,127
| – | – | ﹤0.01% | 1984 |
|
|
2014
Q4 | $113K | Hold |
8,127
| – | – | ﹤0.01% | 1884 |
|
|
2014
Q3 | $73K | Buy |
+8,127
| New | +$87.5K | ﹤0.01% | 2133 |
|
Legal & General Group's GNMK Position: Q2 2021 in Review
Legal & General Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 16,433 shares — an estimated $393K sold.
Legal & General Group first reported a position in GNMK in Q3 2014 and held it in 27 quarters. The position peaked at $393K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Legal & General Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Legal & General Group sold 16,433 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $393K.
- Legal & General Group first reported a position in GenMark Diagnostics, Inc in Q3 2014 and held it in 27 quarters.
- Legal & General Group's GenMark Diagnostics, Inc position peaked at $393K in Q1 2021.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.